Skand Shekhar, MD, Mhs
About Skand Shekhar, MD, Mhs
Skand Shekhar, MD, MHS, serves as the Interim Medical Director of the Clinical Research Unit at NIEHS and works as an Endocrinologist at the National Institutes of Health since 2021. He has a strong background in endocrinology, clinical research, and internal medicine, with a particular focus on endocrine disorders related to histiocytic malignancies.
Work at National Institutes of Health
Skand Shekhar serves as the Medical Director (Interim) of the Clinical Research Unit at the National Institute of Environmental Health Sciences (NIEHS), a position he has held since 2023. He has been an Endocrinologist at the National Institutes of Health since 2021. In addition to his clinical role, he is a faculty member for the NIH Endocrinology Fellowship Program, contributing to the education and training of future endocrinologists. He also plays a leadership role as the associate leader for the Reproductive Physiology and Pathophysiology Group at NIH/NIEHS.
Education and Expertise
Skand Shekhar completed his Doctor of Medicine degree (MBBS) at Delhi University from 2008 to 2014. He pursued his Internal Medicine Residency at Rutgers Robert Wood Johnson Medical School and St. Peter's University Hospital from 2015 to 2018. Following this, he achieved a Fellowship in Endocrinology, focusing on Diabetes and Metabolism, at the National Institutes of Health from 2018 to 2020. He further enhanced his qualifications by obtaining a Master of Health Sciences in Clinical Research from Duke University School of Medicine from 2021 to 2023.
Background
Before joining the National Institutes of Health, Skand Shekhar worked as Chief Resident in Internal Medicine at Rutgers Robert Wood Johnson Medical School and St. Peter's University Hospital from 2017 to 2018. His medical training and experience have equipped him with a strong foundation in internal medicine and endocrinology, allowing him to address complex endocrine disorders.
Special Interests
Skand Shekhar has a special interest in endocrine disorders associated with histiocytic malignancies, particularly Erdheim-Chester Disease. His focus on this area reflects his commitment to advancing understanding and treatment options for rare and complex conditions within the field of endocrinology.